NeoGenomics’ Pharma Services offer two multiplex immunofluorescence platforms: MultiOmyx™ and PhenoImager™ HT
MultiOmyx™ is a proprietary, high-order multiplexing methodology that enables visualization and characterization of up to 60 proteins in a single FFPE tissue section.
High order ≥ 7 plex
Comprehensive analysis of tumor biology
Deep & precise immuno-profiling
PhenoImager™ HT (formerly Vectra Polaris) is an automated system that allows simultaneous detection of 2-6 different markers from a single FFPE tissue slide which would provide a streamlined workflow for implementing refined low-order multiplex panel sets.
Low order 2-6 plex
High-throughput & faster TAT
Assay transfer & validation
PAK4 as a potential marker for poor response to immunotherapy in melanoma patients
Spatial interrogation of tertiary lymphoid structures (TLS) in colorectal carcinoma (CRC) tumor microenvironment (TME) using the MultiOmyxTM assay
Quantitation of CD137 and Nectin-4 expression across multiple tumor types to support indication selection for BT7480, a Bicycle TICA™
Contact Us To Get Started!
Work with us – your premier oncology partner – to optimize cancer care for patients